Background and purpose: The present study reports on the preparation and testing of a sustained delivery system for the immunomodulatory peptide P10 aimed at reducing the in vivo degradation of the peptide and the amount required to elicit a protective immune response against paracoccidioidomycosis. Experimental approach: BALB/c mice were infected with the yeast Paracoccidioides brasiliensis to mimic the chronic form of paracoccidioidomycosis. The animals were treated daily with sulfamethoxazole/trimethoprim alone or combined with peptide P10, either emulsified in Freund`s adjuvant or entrapped in poly(lactic acid-glycolic acid) (PLGA) nanoparticles at different concentrations (1 mu g, 5 mu g, 10 mu g, 20 mu g or 40 mu g center dot 50 mu L-...
The present study reports on the preparation and testing of a desoxycholate amphotericin B (D-AMB) s...
Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by the dimorphic fungus Para...
Objectives: To evaluate whether an engineered synthetic decapeptide (KP) derived from the sequence o...
Background and purpose: The present study reports on the preparation and testing of a sustained deli...
Paracoccidioidomycosis (PCM), a common chronic mycosis in Latin America, is a granulomatous systemic...
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemot...
Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent invasiv...
Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent invasiv...
Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide...
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on ...
A paracoccidioidomicose (PCM), doença sistêmica de caráter granulomatoso, é causada pelo fungo termo...
Paracoccidioidomycosis is a systemic granulomatous disease manifested in the acute/subacute or chron...
Vaccination with peptide 10 (P10), derived from the Paracoccidioides brasiliensis glycoprotein 43 (g...
A paracoccidioidomicose (PCM), doença sistêmica de caráter granulomatoso, causada pelo fungo termodi...
The present study reports on the preparation and testing of a desoxycholate amphotericin B (D-AMB) s...
Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by the dimorphic fungus Para...
Objectives: To evaluate whether an engineered synthetic decapeptide (KP) derived from the sequence o...
Background and purpose: The present study reports on the preparation and testing of a sustained deli...
Paracoccidioidomycosis (PCM), a common chronic mycosis in Latin America, is a granulomatous systemic...
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemot...
Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent invasiv...
Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent invasiv...
Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide...
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on ...
A paracoccidioidomicose (PCM), doença sistêmica de caráter granulomatoso, é causada pelo fungo termo...
Paracoccidioidomycosis is a systemic granulomatous disease manifested in the acute/subacute or chron...
Vaccination with peptide 10 (P10), derived from the Paracoccidioides brasiliensis glycoprotein 43 (g...
A paracoccidioidomicose (PCM), doença sistêmica de caráter granulomatoso, causada pelo fungo termodi...
The present study reports on the preparation and testing of a desoxycholate amphotericin B (D-AMB) s...
Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by the dimorphic fungus Para...
Objectives: To evaluate whether an engineered synthetic decapeptide (KP) derived from the sequence o...